COVID-19: Risk groups, mechanistic insights and challenges
- PMID: 32266754
- PMCID: PMC7235495
- DOI: 10.1111/ijcp.13512
COVID-19: Risk groups, mechanistic insights and challenges
Comment on
-
COVID-19: Social distancing, ACE 2 receptors, protease inhibitors and beyond?Int J Clin Pract. 2020 Jul;74(7):e13503. doi: 10.1111/ijcp.13503. Epub 2020 Apr 6. Int J Clin Pract. 2020. PMID: 32187421 Free PMC article. No abstract available.
References
-
- Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China. Allergy. 2020. Online ahead of print. - PubMed
-
- Team TNCPERE . Vital surveillances: the epidemiological characteristics of an outbreak of 2019 novel coronavirus disease (COVID‐19)‐China, 2020. Available at: http://weekly.chinacdc.cn/en/article/id/e53946e2‐c6c4‐41e9‐9a9b‐fea8db1a.... Accessed March 7, 2020. China CDC Weekly 2020. 2020;2:113‐122. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources